Dopamine, glutamate, and aggression

Dopamine and Glutamate in Psychiatric Disorders

Volumn , Issue , 2005, Pages 237-263

  Miczek, Klaus A ^a   Fish, Eric W ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646361637     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59259-852-6_11     Document Type: Chapter

References (204)

1. Miczek KA, Fish EW, DeBold JF, de Almeida RMM. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and γ-aminobu-tyric acid systems. Psychopharmacology 2002; 163:434-458.
2. Sanders J, Milne S, Brown P, Bell AJ. Assessment of aggression in psychiatric admissions: semistructured interview and case note survey. Br Med J 2000; 320(7242):1112.
3. Love CC, Hunter ME. Violence in public sector psychiatric hospitals. Benchmarking nursing staff injury rates. J Psychosoc Nurs Ment Health Serv 1996; 34(5):30-34.
4. Tardiff K, Sweillam A. Assault, suicide, and mental illness. Arch Gen Psychiatry 1980; 37:164-169.
5. Citrome L, Volavka J. Psychopharmacology of violence: Part I: Assessment and acute treatment. Psychiatri Ann 1997; 27:691-695.
6. Citrome L, Volavka J. Psychopharmacology of violence: Part II: Beyond the acute episode. Psychiatr Ann 1997; 10:696-703.
7. Itil TM, Wadud A. Treatment of human aggression with major tranquilizers, antidepressants and newer psychotropic drugs. J Nerv Ment Dis 1975; 160:83-99.
8. Itil TM. Drug therapy in the management of aggression. In: Brain PF, ed. Multidisciplinary Approaches to Aggression Research. New York: Elsevier/North-Holland Biomedical, 1981:489-501.
9. Leventhal BL, Brodie HKH. The pharmacology of violence. In: Hamburg DA, ed. Biobe-havioral Aspects of Aggression. New York: Alan R. Liss, 1981:85-106.
10. Poeldinger W. Pharmakotherapie der aggressivitaet. Schweiz Arch Neurol Neurochir Psychiatr 1981; 129:147-155.
11. Tupin JP. Psychopharmacology and Aggression. In: Roth LH, ed. Clinical Treatment of the Violent Person. Rockville, MD: U.S. Department of Health and Human Services, 1985: 83-99.
12. Sheard MH. Clinical pharmacology of aggressive behavior. Clin Neuropharmacol 1988; 11:483-492.
13. Connor DF, Boone RT, Steingard RJ, Lopez ID, Melloni RH. Psychopharmacology and aggression: II. A meta-analysis of nonstimulant medication effects on overt aggression-related behaviors in youth with SED. J Emot Behav Disord 2003; 11(3):157-168.
14. Humble F, Berk M. Pharmacological management of aggression and violence. Hum Psychopharmacol 2003; 18(6):423-436.
15. Swann AC. Neuroreceptor mechanisms of aggression and its treatment. J Clin Psychiatry 2003; 64:26-35.
16. Monroe RR. Brain Dysfunction in Aggressive Criminals. Lexington: DC Heath and Company, 1978.
17. Bear DM, Fedio P. Quantitative analysis of interictal behavior in temporal lobe epilepsy. Arch Neurol 1977; 34(8):454-467.
18. Siegel A, Mirsky AF. The neurobiology of violence and aggression. In: Reiss AJ, Jr., ed. Understanding and Preventing Violence. Biobehavioral Influences. Washington, DC: National Academy Press, 1994:59-172.
19. Mirsky AF, Harman N. On aggressive behavior and brain disease-some questions and possible relationships derived from the study of men and monkeys. In: Whalen RF, ed. The Neuropsychology of Aggression. New York: Plenum Press, 1974:185-210.
20. Weiger WA, Bear DM. An approach to the neurology of aggression. J Psychiatr Res 1988; 22:85-98.
21. Scott JP. Aggression. Chicago: University of Chicago Press, 1958.
22. Darwin C. The Expression of the Emotions in Man and Animals. 1st ed. London: John Murray, 1872.
23. Blanchard RJ, Wall PM, Blanchard DC. Problems in the study of rodent aggression. Horm Behav 2003; 44(3):161-170.
24. Miczek KA, Fish EW, De Bold JF. Neurosteroids, GABAA receptors, and escalated aggressive behavior. Horm Behav 2003; 44(3):242-257.
25. Lederhendler II. Aggression and violence: perspectives on integrating animal and human research approaches. Horm Behav 2003; 44(3):156-160.
26. Miczek KA. Research on animal aggression: emerging successes for understanding determinants of human violence. In: Carrol ME, Overmier JB, ed. Animal Research and Human Health: Advancing Human Welfare Through Behavioral Science. Washington, DC: American Psychological Association, 2001.
27. Brain PF, Benton D. The Biology of Aggression. 1st ed. Rockville, MD: Sijthoff and Noordhoff, 1981.
28. Grant EC, Mackintosh JH. A comparison of the social postures of some common laboratory rodents. Behaviour 1963; 21:246-295.
29. Blanchard RJ, Blanchard CD. Aggressive behavior in the rat. Behav Biol 1977; 21:197-224.
30. Scott JP, Fredericson E. The causes of fighting in mice and rats. Physiol Zool 1951; 24:273-309.
31. Azrin NH, Hutchinson RR, Hake DF Pain-induced fighting in the squirrel monkey. J Exp Anal Behav 1963; 6:620.
32. Brady JV, Nauta WJH. Subcortical mechanisms in emotional behavior: affective changes following septal forebrain lesion in the albino rat. J Comp Physiol Psychol 1953; 46:339-346.
33. Seggie J. Effect of adrenalectomy or gonadectomy on affective behavior changes following septal lesions in the rat. J Comp Physiol Psychol 1971; 74(1):11-19.
34. Pinel JPJ, Treit D, Rovner LI. Temporal lobe aggression in rats. Science 1977; 197:1088-1089.
35. De Molina AF, Hunsperger RW. Organization of the subcortical system governing defense and flight reactions in the cat. J Physiol 1962; 160:200-213.
36. Siegel A, Roeling TAP, Gregg TR, Kruk MR. Neuropharmacology of brain-stimulation-evoked aggression. Neurosci Biobehav Rev 1999; 23:359-389.
37. Blanchard DC, Griebel G, Blanchard RJ. Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci Biobehav Rev 2001; 25(3):205-218.
38. Flannelly KJ, Flannelly L. Time course of postpartum aggression in rats (Rattus norvegicus). J Comp Psychol 1987; 101:101-103.
39. Blanchard DC, Blanchard RJ. Ethoexperimental approaches to the biology of emotion. Ann Rev Psychol 1988; 39:43-68.
40. Svare B, Gandelman R. A longitudinal analysis of maternal aggression in Rockland-Swiss albino mice. Dev Psychobiol 1976; 9:437-446.
41. Svare B, Betteridge C, Katz D, Samuels O. Some situational and experiential determinants of maternal aggression in mice. Physiol Behav 1981; 26:253-258.
42. Blanchard RJ, Blanchard DC. Attack and defense in rodents as ethoexperimental models for the study of emotion. Prog Neuropsychopharmacol Biol Psychiatry. Great Britain: Pergamon Press, 1989:S3-S14.
43. Lonstein JS, Stern JM. Site and behavioral specificity of periaqueductal gray lesions on postpartum sexual, maternal, and aggressive behaviors in rats. Brain Res 1998; 804(1):21-35.
44. Miczek KA, Haney M, Tidey J, Vatne T, Weerts E, DeBold JF. Temporal and sequential patterns of agonistic behavior: Effects of alcohol, anxiolytics and psychomotor stimulants. Psychopharmacology 1989; 97:149-151.
45. Miczek KA, Weerts EM, Tornatzky W, DeBold JF, Vatne TM. Alcohol and "bursts" of aggressive behavior: ethological analysis of individual differences in rats. Psychopharmacology 1992; 107:551-563.
46. Eibl-Eibesfeldt I. Beiträge zur Biologie der Haus-und der Ährenmaus nebst einigen Beobachtungen an anderen Nagern. Z Tierpsychol 1950; 7:558-587.
47. Scott JP. Agonistic behavior of mice and rats: A review. Am Zool 1966; 6:683-701.
48. Eibl-Eibesfeldt I. The fighting behavior of animals. Sci Am 1961; 203:112-120.
49. Lorenz K. On Aggression. London: Methuen, 1966.
50. Rose RM, Holaday JW, Bernstein IS. Plasma testosterone, dominance rank and aggressive behavior in a group of male rhesus monkeys. Nature 1971; 231:366-368.
51. Winslow JT, Miczek KA. Social status as determinant of alcohol effects on aggressive behavior in squirrel monkeys (Saimiri sciureus). Psychopharmacology 1985; 85:167-172.
52. Miczek KA, Barros HM, Sakoda L, Weerts EM. Alcohol and heightened aggression in individual mice. Alcohol Clin Exp Res 1998; 22:1698-1705.
53. Dollard J, Doob L, Miller N, Mowrer O, Sears R. Frustration and Aggression. New Haven: Yale University Press, 1939.
54. Cherek DR, Heistad GT. Fixed-interval induced aggression. Psychon Sci 1971; 25:7-8.
55. 1B receptor agonist. Neuropsychopharmacology 2002; 27:171-181.
56. Leshner AI, Nock BL. The effects of experience on agonistic responding: an expectancy theory interpretation. Behav Biol 1976; 17:561-566.
57. Potegal M, Tenbrink L. Behavior of attack-primed and attack-satiated female golden hamsters (Mesocricetus auratus). J Comp Psychol 1984; 98:66-75.
58. Potegal M. The persistence of attack satiation in female golden hamsters. Aggress Behav 1984; 10:303-307.
59. 1B receptor agonist CP-94, 253. Psychopharmacology 1999; 146:391-399.
60. Fish EW, DeBold JF, Miczek KA. Aggressive behavior as a reinforcer in mice: activation by allopregnanolone. Psychopharmacology 2002; 163(3-4):459-466.
61. de Boer SF, Van Der Vegt BJ, Koolhaas JM. Individual variation in aggression of feral rodent strains: a standard for the genetics of aggression and violence? Behav Genet 2003; 33(5):485-501.
62. Halasz J, Liposits Z, Kruk MR, Haller J. Neural background of glucocorticoid dysfunction-induced abnormal aggression in rats: involvement of fear-and stress-related structures. Eur J Neurosci 2002; 15(3):561-569.
63. Miczek KA, Covington HE, III, Clark R. Social defeat vs. impulsive aggressive experiences in rats: sensitization for cocaine self-administration. Soc Neurosci Abstr 2003.
64. Tecott LH, Barondes SH. Genes and aggressiveness. Behavioral genetics. Curr Biol 1996; 6(3):238-240.
65. Van Erp AMM, Miczek KA. Aggressive behavior, increased accumbal dopamine, and decreased cortical serotonin in rats. J Neurosci 2000; 20(24):9320-9325.
66. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992; 149:999-1010.
67. Sinha R. How does stress increase risk of drug abuse and relapse? Psychopharmacology 2001; 158(4):343-359.
68. Martinez M, Calvo-Torrent A, Herbert J. Mapping brain response to social stress in rodents with c-fos expression: a review. Stress 2002; 5(1):3-13.
69. Miczek KA, Nikulina E, Kream R, Carter G, Espejo E. Behavioral sensitization to cocaine after a brief social defeat stress: c-fos expression in the PAG. Psychopharmacology 1999; 141:225-234.
70. Nikulina EM, Covington HE III, Ganshow RP, Hammer RP Jr., Miczek KA. Long-term behavioral and neuronal cross-sensitization to amphetamine induced by repeated brief social defeat stress: Fos in the ventral tegmental area and amygdala. Neuroscience 2004; 123:857-865.
71. Miczek KA, Covington HE, III, Nikulina EM, Hammer RP, Jr. Aggression and defeat: persistent effects on cocaine self-administration and gene expression in peptidergic and aminergic mesocorticolimbic circuits. Neurosci Biobehav Rev 2004; 27:787-802. Review.
72. Covington HE, Miczek KA. NMDA receptor antagonists block behavioral sensitization, but not enhanced cocaine self-administration after social defeat stress. Soc Neurosci Abstr 2002; 28:897-911.
73. Paquet M, Tremblay M, Soghomonian JJ, Smith Y. AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: an immunohistochemical and in situ hybridization study. J Neurosci 1997; 17(4):1377-1396.
74. Redmond DE, Maas JW, Kling A, Graham CW, Dekirmenjian H. Social behavior of monkeys selectively depleted of monoamines. Science 1971; 174:428-431.
75. Redmond DE, Jr., Maas JW, Kling A, Dekirmenjian H. Changes in primate social behavior after treatment with alpha-methyl-para-tyrosine. Psychosom Med 1971; 33:97-113.
76. Eichelman BSJ, Thoa NB, Ng KY. Facilitated aggression in the rat following 6-hydroxy-dopamine administration. Physiol Behav 1972; 8:1-3.
77. Pucilowski O, Kostowski W, Bidzinski A, Hauptmann M. Effect of 6-hydroxydopamine-induced lesions of A10 dopaminergic neurons on aggressive behavior in rats. Pharmacol Biochem Behav 1982; 16:547-551.
78. Mos J, Van Valkenburg CFM. Specific effect on social stress and aggression on regional dopamine metabolism in rat brain. Neurosci Lett 1979; 15:325-327.
79. Hadfield MG. Dopamine: mesocortical versus nigrostriatal uptake in isolated fighting mice and controls. Behav Brain Res 1983; 7:269-281.
80. Haney M, Noda K, Kream R, Miczek KA. Regional serotonin and dopamine activity: sensitivity to amphetamine and aggressive behavior in mice. Aggress Behav 1990; 16:259-270.
81. Puglisi-Allegra S, Cabib S. Effects of defeat experiences on dopamine metabolism in different brain areas of the mouse. Aggress Behav 1990; 16:271-284.
82. Muir JL, Everitt BJ, Robbins TW. The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb Cortex 1996; 6:470-481.
83. Tidey JW, Miczek KA. Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study. Brain Res 1996; 721:140-149.
84. Thierry AM, Tassin JP, Blanc G, Glowinski J. Selective activation of the mesocortical DA system by stress. Nature 1976; 263:242-243.
85. Abercrombie ED, Keefe KA, DiFrischia DS, Zigmond MJ. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 1989; 52:1655-1658.
86. Tidey JW, Miczek KA. Acquisition of cocaine self-administration after social stress: role of accumbens dopamine. Psychopharmacology 1997; 130:203-212.
87. Ferrari PF, Van Erp AMM, Tornatzky W, Miczek KA. Accumbal dopamine and serotonin in anticipation of the next aggressive episode in rats. Eur J Neurosci 2003; 17(2):371-378.
88. Senault B. Syndrome agressif induit par l'apomorphine chez le Rat. J Physiol 1968; 60:543-544.
89. Senault B. Influence de l'isolement sur le comportement d'agressivit, intraspécifique induit par l'apomorphine chez le rat. Psychopharmacologia 1971; 20:389-394.
90. Crowley TJ. Dose-dependent facilitation or supression of rat fighting by methamphetamine, phenobarbital, or imipramine. Psychopharmacologia 1972; 27:213-222.
91. Hasselager E, Rolinski Z, Randrup A. Specific antagonism by dopamine inhibitors of items of amphetamine induced aggressive behaviour. Psychopharmacologia 1972; 24:485-495.
92. Miczek KA. Intraspecies aggression in rats: effects of d-amphetamine and chlordiazepox-ide. Psychopharmacologia 1974; 39:275-301.
93. Puech AJ, Simon P, Chermat R, Boisseir JR. Profil neuropsychopharmacologique de l' apomorphine. J Pharmacol 1974; 5:241-254.
94. Ray A, Sharma KK, Alkondon M, Sen P. Possible interrelationship between the biogenic amines involved in the modulation of footshock aggression in rats. Arch Int Pharmacodyn Ther 1983; 265:36-41.
95. Winslow JT, Miczek KA. Habituation of aggression in mice: Pharmacological evidence of catecholaminergic and serotonergic mediation. Psychopharmacology 1983; 81:286-291.
96. Hodge GK, Butcher LL. Catecholamine correlates of isolation-induced aggression in mice. Eur J Pharmacol 1975; 31:81-93.
97. Miczek KA, O'Donnell JM. Intruder-evoked aggression in isolated and nonisolated mice: effects of psychomotor stimulants and L-dopa. Psychopharmacology 1978; 57:47-55.
98. Miczek KA, Yoshimura H. Disruption of primate social behavior by D-amphetamine and cocaine: differential antagonism by antipsychotics. Psychopharmacology 1982; 76:163-171.
99. Miczek KA, Haney M. Psychomotor stimulant effects of D-amphetamine, MDMA and PCP: aggressive and schedule-controlled behavior in mice. Psychopharmacology 1994; 115:358-365.
100. Nikulina EM, Marchand JE, Kream RM, Miczek KA. Behavioral sensitization to cocaine after a brief social stress is accompanied by changes in fos expression in the murine brainstem. Brain Res 1998; 810(1-2):200-210.
101. Nikulina EM, Hammer RP, Jr., Miczek KA, Kream RM. Social defeat stress increases expression of mu-opioid receptor mRNA in rat ventral tegmental area. Neuroreport 1999; 10(14):3015-3019.
102. Diana M, Pistis M, Muntoni A, Gessa G. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J Pharmacol Exp Ther 1995; 272(2):781-785.
103. Nowycky MC, Walters JR, Roth RH. Dopaminergic-neurons-effect of acute and chronic morphine administration on single cell activity and transmitter metabolism. J Neural Transm 1978; 42(2):99-116.
104. Gianutsos G, Lal H. Narcotic analgesics and aggression. In: Valzelli L, ed. Modern Problems of Pharmopsychiatry: Psychopharmacology of Aggression. New York: S. Karger, 1978: 114-138.
105. Kantak KM, Miczek KA. Social, motor, and autonomic signs of morphine withdrawal: differential sensitivities to catecholaminergic drugs in mice. Psychopharmacology 1988; 96:468-476.
106. Tidey JW, Miczek KA. Heightened aggressive behavior during morphine withdrawal: effects of D-amphetamine. Psychopharmacology 1992; 107:297-302.
107. Janssen PAJ, Jageneau AH, Niemegeers JE. Effects of various drugs on isolation-induced fighting behavior of male mice. J Pharmacol Exp Ther 1960; 129:471-475.
108. Rolinski Z. Pharmacological studies on isolation-induced aggressiveness in mice in relation to biogenic amines. Pol J Pharmacol Pharm 1975; 27(1):37-44.
109. Krsiak M, Sulcova A, Tomasikova Z, Dlohozkova N, Kosar E, Masek K. Drug effects on attack, defense and escape in mice. Pharmacol Biochem Behav 1981; 14:47-52.
110. Olivier B, van Dalen D. Social behaviour in rats and mice: an ethologically based model for differentiating psychoactive drugs. Aggress Behav 1982; 8:163-168.
111. Yudofsky SC, Silver JM, Schneider SE. Pharmacologic treatment of aggression. Psychiatr Ann 1987; 17:397-406.
112. Brizer DA. Psychopharmacology and the management of violent patients. Psychiatr Clin North Am 1988; 11:551-568.
113. McMillen BA, DaVanzo EA, Song AH, Scott SM, Rodriguez ME. Effects of classical and atypical antipsychotic drugs on isolation-induced aggression in male mice. Eur J Pharmacol 1989; 160:149-153.
114. Tidey JW, Miczek KA. Effects of SKF38393 and quinpirole on patterns of aggressive, motor and schedule-controlled behaviors in mice. Behav Pharmacol 1992; 3:553-565.
115. Tidey JW, Miczek KA. Morphine withdrawal aggression: modification with D1 and D2 receptor agonists. Psychopharmacology 1992; 108:177-184.
116. Aguilar MA, Minarro J, Perez-Iranzo N, Simon VM. Behavioral profile of raclopride in agonistic encounters between male mice. Pharmacol Biochem Behav 1994; 47(3):753-756.
117. Rodriguez-Arias M, Pinazo J, Minarro J, Stinus L. Effects of SCH 23390, raclopride, and haloperidol on morphine withdrawal-induced aggression in male mice. Pharmacol Biochem Behav 1999; 64(1):123-130.
118. Fowler SC, Liou JR. Haloperidol, raclopride, and eticlopride induce microcatalepsy during operant performance in rats, but clozapine and SCH 23390 do not. Psychopharmacology 1998; 140(1):81-90.
119. Paulus MP, Geyer MA. A scaling approach to find order parameters quantifying the effects of dopaminergic agents on unconditioned motor activity in rats. Prog Neuropsychopharmacol Biol Psychiatry 1991; 15(6):903-919.
120. Rodriguez-Arias M, Minarro J, Aguilar MA, Pinazo J, Simon VM. Effects of risperidone and SCH 23390 on isolation-induced aggression in male mice. Eur Neuropsychopharmacol 1998; 8:95-103.
121. Rodriguez-Arias M, Felip CM, Broseta I, Minarro J. The dopamine D3 antagonist U-99194A maleate increases social behaviors of isolation-induced aggressive male mice. Psychopharmacology 1999; 144(1):90-94.
122. 2 dopamine receptor agonists differentially modulate isolation-induced social-emotional reactivity in mice. Behav Brain Res 2000; 114(1-2):107-117.
123. Glazer WM, Dickson RA. Clozapine reduces violence and persistent aggression in schizophrenia. J Clin Psychiatry 1998; 59 (Suppl 3):8-14.
124. Hector RI. The use of clozapine in the treatment of aggressive schizophrenia. Can J Psychiatry 1998; 43(5):466-472.
125. Volavka J. The effects of clozapine on aggression and substance abuse in schizophrenic patients. J Clin Psychiatry 1999; 60 (Suppl 12):43-46.
126. Rabinowitz J, Avnon M, Rosenberg V. Effect of clozapine on physical and verbal aggression. Schizophr Res 1996; 22(3):249-255.
127. Spivak B, Roitman S, Vered Y, Mester R, Graff E, Talmon Y, et al. Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine. Clin Neuropharmacol 1998; 21:245-250.
128. Chalasani L, Kant R, Chengappa R. Clozapine impact on clinical outcomes and aggression in severely ill adolescents with childhood-onset schizophrenia. Can J Psychiatry 2001; 46(10):965-968.
129. Bhana N, Foster RH, Olney R, Plosker GL. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs 2001; 61(1):111-161.
130. Kennedy JS, Bymaster FP, Schuh L, Calligaro DO, Nomikos G, Felder CC, et al. A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data. Int J Geriatr Psychiatry 2001; 16(S1):S33-S61.
131. Barratt ES. The use of anticonvulsants in aggression and violence. Psychopharmacol Bull 1993; 29:75-81.
132. Pabis DJ, Stanislav SW. Pharmacotherapy of aggressive behavior. Ann Pharmacother 1996; 30:278-287.
133. Lindenmayer JP, Kotsaftis A. Use of sodium valproate in violent and aggressive behaviors: a critical review. J Clin Psychiatry 2000; 61(2):123-128.
134. Marsh L, Krauss GL. Aggression and violence in patients with epilepsy. Epilepsy Behav 2000; 1(3):160-168.
135. Fenwick P. The nature and management of aggression in epilepsy. J Neuropsychiatry Clin Neurosci 1989; 1(4):418-425.
136. Adamec RE. Does kindling model anything clinically relevant? Biol Psychiatry 1990; 27(3):249-279.
137. Adamec R, Young B. Neuroplasticity in specific limbic system circuits may mediate specific kindling induced changes in animal affect-implications for understanding anxiety associated with epilepsy. Neurosci Biobehav Rev 2000; 24(7):705-723.
138. Kalynchuk LE. Long-term amygdala kindling in rats as a model for the study of interictal emotionality in temporal lobe epilepsy. Neurosci Biobehav Rev 2000; 24(7):691-704.
139. Kalynchuk LE, Pinel JP, Triet D. Characterization of the defensive natures of kindling-induced emotionality. Behav Neurosci 1999; 113:766-775.
140. Adamec RE. Lasting effects of FG-7142 on anxiety, aggression and limbic physiology in the cat. J Psychopharmacol 1993; 7(3):232-248.
141. Naalsund LU, Allen CN, Fonnum F. Changes in neurobiological parameters in the hippocampus after exposure to trimethyltin. Neurotoxicology 1985; 6(3):145-158.
142. Patel M, Ardelt BK, Yim GK, Isom GE. Interaction of trimethyltin with hippocampal glutamate. Neurotoxicology 1990; 11(4):601-608.
143. Lipe GW, Ali SF, Newport GD, Scallet AC, Slikker W Jr. Effect of trimethyltin on amino acid concentrations in different regions of the mouse brain. Pharmacol Toxicol 1991; 68(6):450-455.
144. Dawson R, Jr., Patterson TA, Eppler B. Endogenous excitatory amino acid release from brain slices and astrocyte cultures evoked by trimethyltin and other neurotoxic agents. Neurochem Res 1995; 20(7):847-858.
145. Ishida N, Akaike M, Tsutsumi S, et al. Trimethyltin syndrome as a hippocampal degeneration model: temporal changes and neurochemical features of seizure susceptibility and learning impairment. Neuroscience 1997; 81(4):1183-1191.
146. Raine A, Buchsbaum MS, Stanley J, Lottenberg S, Abel L, Stoddard J. Selective reductions in prefrontal glucose metabolism in murderers. Biol Psychiatry 1994; 36(6):365-373.
147. Raine A, Lencz T, Bihrle S, LaCasse L, Colletti P. Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder. Arch Gen Psychiatry 2000; 57(2):119-127.
148. Best M, Williams JM, Coccaro EF Evidence for a dysfunctional prefrontal circuit in patients with an impulsive aggressive disorder. Proc Natl Acad Sci USA 2002; 99(12): 8448-8453.
149. Juhasz C, Behen ME, Muzik O, Chugani DC, Chugani HT Bilateral medial prefrontal and temporal neocortical hypometabolism in children with epilepsy and aggression. Epilepsia 2001; 42(8):991-1001.
150. King BH, Wright DM, Handen BL, et al. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. J Am Acad Child Adolesc Psychiatry 2001; 40(6):658-665.
151. Rewerski W, Kostowski W, Piechocki T, Rylski M. The effects of some hallucinogens on aggressiveness of mice and rats. I. Pharmacology 1971; 5:314-320.
152. Burkhalter JE, Balster RL. The effects of phencyclidine on isolation-induced aggression in mice. Psychol Rep 1979; 45:571-576.
153. Wilmot CA, Vander Wende C, Spoerlein MT. The effects of phencyclidine on fighting in differentially housed mice. Pharmacol Biochem Behav 1987; 28:341-346.
154. Krsiak M. Behavioral changes and aggressivity evoked by drugs in mice. Res Commun Chem Pathol Pharmacol 1974; 7:237-257.
155. McAllister KH. Ethological analysis of the effects of MK-801 upon aggressive male mice: similarity to chlordiazepoxide. Pharmacol Biochem Behav 1990; 37(1):101-106.
156. Musty RE, Consroe PF Phencyclidine produces aggressive behavior in rapid eye movement sleep deprived rats. Life Sci 1982; 30:1733-1738.
157. Tyler CB, Miczek KA. Effects of phencyclidine on aggressive behavior in mice. Pharmacol Biochem Behav 1982; 17:503-510.
158. Lang A, Harro J, Soosaar A, et al. Role of A'-methyl-D-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behaviour in rats. Naunyn Schmiedeberg Arch Pharmacol 1995; 351(4):363-370.
159. Belozertseva IV, Bespalov AY. Effects of NMDA receptor channel blockade on aggression in isolated male mice. Aggress Behav 1999; 25:381-396.
160. Sukhotina IA, Bespalov AY. Effects of the NMDA receptor channel blockers memantine and MRZ 2/579 on morphine withdrawal-facilitated aggression in mice. Psychopharmacology 2000; 149(4):345-350.
161. Schubert K, Shaikh MB, Siegel A. NMDA receptors in the midbrain periaqueductal gray mediate hypothalamically evoked hissing behavior in the cat. Brain Res 1996; 762(1-2):80-90.
162. Bandler R, Depaulis A, Vergnes M. Identification of midbrain neurons mediating defensive behaviour in the rat by microinjections of excitatory amino acids. Behav Brain Res 1985; 15:107-119.
163. Shaikh MB, Barrett JA, Siegel A. The pathways mediating affective defense and quiet biting attack behavior from the midbrain central gray of the cat: an autoradiographic study. Brain Res 1987; 437:9-25.
164. Brodkin ES, Goforth SA, Keene AH, Fossella JA, Silver LM. Identification of quantitative trait loci that affect aggressive behavior in mice. J Neurosci 2002; 22(3):1165-1170.
165. Anagnostopoulos AV, Mobraaten LE, Sharp JJ, Davisson MT. Transgenic and knockout databases: behavioral profiles of mouse mutants. Physiol Behav 2001; 73(5):675-689.
166. Miczek KA, Maxson SC, Fish EW, Faccidomo S. Aggressive behavioral phenotypes in mice. Behav Brain Res 2001; 125(1-2):167-181.
167. Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 2001; 41:237-260.
168. Kalivas PW, McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology 2003; 168(1-2):44-56.
169. Starr MS. The role of dopamine in epilepsy. Synapse 1996; 22(2):159-194.
170. Calabresi P, Pisani A, Mercuri NB, Bernardi G. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci 1996; 19(1):19-24.
171. Sesack SR, Pickel VM. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 1992; 320(2):145-160.
172. Johnson SW, Seutin V, North RA. Burst firing in dopamine neurons induced by A-methyl-D-aspartate: role of electrogenic sodium pump. Science 1992; 258(5082):665-667.
173. Tong ZY, Overton PG, Clark D. Stimulation of the prefrontal cortex in the rat induces patterns of activity in midbrain dopaminergic neurons which resemble natural burst events. Synapse 1996; 22(3):195-208.
174. Takahata R, Moghaddam B. Target-specific glutamatergic regulation of dopamine neurons in the ventral tegmental area. J Neurochem 2000; 75(4):1775-1778.
175. Carr DB, Sesack SR. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J Neurosci 2000; 20(10):3864-3873.
176. Van Erp AMM, Miczek KA. Aggressive behavior, increased accumbal dopamine and decreased cortical serotonin in rats. J Neurosci 2000; 15:9320-9325.
177. Pfaus JG, Damsma G, Nomikos GG, et al. Sexual behavior enhances central dopamine transmission in the male rat. Brain Res 1990; 530:345-348.
178. Bassareo V, Di Chiara G. Differential influence of associative and nonassociative learning mechanisms on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum. J Neurosci 1997; 17(2):851-861.
179. Mathe JM, Nomikos GG, Schilstrom B, Svensson TH. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens. J Neurosci Res 1998; 51(5):583-592.
180. Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, Varney MA. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 2003; 117(3):697-706.
181. Takahata R, Moghaddam B. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine. Neuropsychophar-macology 2003; 28(6):1117-1124.
182. Spanagel R, Eilbacher B, Wilke R. Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat-a pharmacokinetic microdialysis study. Eur J Pharmacol 1994; 262(1-2):21-26.
183. Hertel P, Mathe JM, Nomikos GG, Iurlo M, Mathe AA, Svensson TH. Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat. Behav Brain Res 1995; 72(1-2):103-114.
184. 2A/2C receptor agonist and antagonist on phencyclidine-induced dopamine release in rat medial prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry 1999; 23(7):1259-1275.
185. Carr DB, O'Donnell P, Card JP, Sesack SR. Dopamine terminals in the rat prefrontal cortex synapse on pyramidal cells that project to the nucleus accumbens. J Neurosci 1999; 19:11049-11060.
186. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979; 205(4409): 929-932.
187. Roth BL, Tandra S, Burgess LH, Sibley DR, Meltzer HY D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs. Psychophar-macology 1995; 120:365-368.
188. Bakshi VP, Swerdlow NR, Geyer MA. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 1994; 271(2): 787-794.
189. Gleason SD, Shannon HE. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychophar-macology 1997; 129(1):79-84.
190. Mrzljak L, Bergson C, Pappy M, Huff R, Levenson R, Goldman-Rakic PS. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 1996; 381(6579):245-248.
191. Wang X, Zhong P, Gu Z, Yan Z. Regulation of NMDA receptors by dopamine D4 signaling in prefrontal cortex. J Neurosci 2003; 23(30):9852-9861.
192. Rubinstein M, Cepeda C, Hurst RS, Flores-Hernandez J, Ariano MA, Falzone TL, et al. Dopamine D4 receptor-deficient mice display cortical hyperexcitability. J Neurosci 2001; 21(11):3756-3763.
193. Lee JJ, Croucher MJ. Actions of group I and group II metabotropic glutamate receptor ligands on 5-hydroxytryptamine release in the rat cerebral cortex in vivo: differential roles in the regulation of central serotonergic neurotransmission. Neuroscience 2003; 117(3): 671-679.
194. Lee HS, Kim MA, Valentino RJ, Waterhouse BD. Glutamatergic afferent projections to the dorsal raphe nucleus of the rat. Brain Res 2003; 963(1-2):57-71.
195. Tao R, Auerbach SB. Influence of inhibitory and excitatory inputs on serotonin efflux differs in the dorsal and median raphe nuclei. Brain Res 2003; 961(1):109-120.
196. Maione S, Palazzo E, de Novellis V, Stella L, Leyva J, Rossi F. Metabotropic glutamate receptors modulate serotonin release in the rat periaqueductal gray matter. Naunyn Schmiedeberg Arch Pharmacol 1998; 358(4):411-417.
197. Guan XM, McBride WJ. Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res Bull 1989; 23:541-547.
198. Parsons L, Justice J. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 1993; 606:195-199.
199. Peyron C, Luppi PH, Kitahama K, Fort P, Hermann DM, Jouvet M. Origin of the dopaminergic innervation of the rat dorsal raphe nucleus. Neuroreport 1995; 6(18):2527-2531.
200. Coccaro EF Central serotonin and impulsive aggression. Br J Psychiatry 1989; 155:52-62.
201. Virkkunen M, Linnoila M. Brain serotonin, Type II alcoholism and impulsive violence. J Stud Alcohol 1993; Suppl 11:163-169.
202. Raine A, Buchsbaum M, LaCasse L. Brain abnormalities in murderers indicated by positron emission tomography. Biol Psychiatry 1997; 42(6):495-508.
203. Raine A, Meloy JR, Bihrle S, Stoddard J, LaCasse L, Buchsbaum MS. Reduced prefrontal and increased subcortical brain functioning assessed using positron emission tomography in predatory and affective murderers. Behav Sci Law 1998; 16(3):319-332.
204. Moghaddam B. Stress preferentially increases extraneuronal levels of excitatory amino-acids in the prefrontal cortex-Comparison to hippocampus and basal ganglia. J Neurochem 1993; 60(5):1650-1657.